CompletedPhase 3NCT04730037

Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)

Studying Chronic thromboembolic pulmonary hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kyushu University
Principal Investigator
Kohtaro Abe
Kyushu University Hospital
Intervention
Edoxaban(drug)
Enrollment
74 enrolled
Eligibility
20-85 years · All sexes
Timeline
20212023

Study locations (1)

Collaborators

Daiichi Sankyo Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04730037 on ClinicalTrials.gov

Other trials for Chronic thromboembolic pulmonary hypertension

Additional recruiting or active studies for the same condition.

See all trials for Chronic thromboembolic pulmonary hypertension

← Back to all trials